Phuong N. Huynh

Array ( [id] => 9930888 [patent_doc_number] => 20150079080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'NOVEL ANTI-IGF-IR ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/492636 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 60490 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11857951 [patent_doc_number] => 09737617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases' [patent_app_type] => utility [patent_app_number] => 14/491189 [patent_app_country] => US [patent_app_date] => 2014-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 41334 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799037 [patent_doc_number] => 20150010982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses' [patent_app_type] => utility [patent_app_number] => 14/488921 [patent_app_country] => US [patent_app_date] => 2014-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19314 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14488921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11031565 [patent_doc_number] => 20160228521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'MANAGING IMMUNE RESPONSES IN TRANSPLANTATION' [patent_app_type] => utility [patent_app_number] => 15/022052 [patent_app_country] => US [patent_app_date] => 2014-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26106 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10208395 [patent_doc_number] => 20150093384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'Methods and systems for multi-antibody therapies' [patent_app_type] => utility [patent_app_number] => 14/484505 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9164 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17435950 [patent_doc_number] => 11261262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Readily isolated bispecific binding molecules with native format having mutated constant regions [patent_app_type] => utility [patent_app_number] => 14/475892 [patent_app_country] => US [patent_app_date] => 2014-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 25 [patent_no_of_words] => 10724 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14475892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15751345 [patent_doc_number] => 10617755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-14 [patent_title] => Combination therapy for the treatment of glioblastoma [patent_app_type] => utility [patent_app_number] => 14/470443 [patent_app_country] => US [patent_app_date] => 2014-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19177 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864193 [patent_doc_number] => 20150044213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION' [patent_app_type] => utility [patent_app_number] => 14/462065 [patent_app_country] => US [patent_app_date] => 2014-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8568 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10945807 [patent_doc_number] => 20140348828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'INHIBITION OF SECRETION FROM NON-NEURONAL CELLS' [patent_app_type] => utility [patent_app_number] => 14/459955 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21678 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838517 [patent_doc_number] => 20150030597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/454820 [patent_app_country] => US [patent_app_date] => 2014-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26642 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14454820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858665 [patent_doc_number] => 20150038682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'ANTIBODIES OR FUSION PROTEINS MULTIMERIZED VIA HOMOMULTIMERIZING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/449076 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26202 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14449076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13885515 [patent_doc_number] => 10195289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-05 [patent_title] => Engineered polypeptide conjugates using transglutaminase [patent_app_type] => utility [patent_app_number] => 14/908492 [patent_app_country] => US [patent_app_date] => 2014-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 17546 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9916712 [patent_doc_number] => 20150071917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'METHODS AND PRODUCTS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/330619 [patent_app_country] => US [patent_app_date] => 2014-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21547 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14330619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9805242 [patent_doc_number] => 20150017187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 14/328532 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 70178 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14243953 [patent_doc_number] => 10272159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-30 [patent_title] => IgG Fc fragment for a drug carrier and method for the preparation thereof [patent_app_type] => utility [patent_app_number] => 14/327064 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 20321 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14327064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11879665 [patent_doc_number] => 09750820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-05 [patent_title] => 'IgG Fc fragment for a drug carrier and method for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 14/327120 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 22092 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14327120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919187 [patent_doc_number] => 20140322206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION' [patent_app_type] => utility [patent_app_number] => 14/324630 [patent_app_country] => US [patent_app_date] => 2014-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11941 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15054905 [patent_doc_number] => 10457741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Chicken antibody transformed into cysteine and site-specific conjugation using same [patent_app_type] => utility [patent_app_number] => 14/901245 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 32 [patent_no_of_words] => 7238 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10280066 [patent_doc_number] => 20150165063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => '1-(CHLOROMETHYL)-2,3-DIHYDRO-1H-BENZO[E]INDOLE DIMER ANTIBODY-DRUG CONJUGATE COMPOUNDS, AND METHODS OF USE AND TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/305643 [patent_app_country] => US [patent_app_date] => 2014-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 78317 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14305643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9771153 [patent_doc_number] => 20140294816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/303973 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 31395 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14303973 [rel_patent_id] =>[rel_patent_doc_number] =>)